OXYTROL FOR WOMEN Drug Patent Profile
✉ Email this page to a colleague
When do Oxytrol For Women patents expire, and what generic alternatives are available?
Oxytrol For Women is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in OXYTROL FOR WOMEN is oxybutynin. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the oxybutynin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXYTROL FOR WOMEN?
- What are the global sales for OXYTROL FOR WOMEN?
- What is Average Wholesale Price for OXYTROL FOR WOMEN?
Summary for OXYTROL FOR WOMEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 7 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for OXYTROL FOR WOMEN |
What excipients (inactive ingredients) are in OXYTROL FOR WOMEN? | OXYTROL FOR WOMEN excipients list |
DailyMed Link: | OXYTROL FOR WOMEN at DailyMed |
![OXYTROL FOR WOMEN drug patent expirations Drug patent expirations by year for OXYTROL FOR WOMEN](/p/graph/s/t/OXYTROL_FOR_WOMEN-patent-expirations.png)
![Drug Prices for OXYTROL FOR WOMEN](/p/graph/drug-price/OXYTROL+FOR+WOMEN.png)
Recent Clinical Trials for OXYTROL FOR WOMEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Astellas Scientific & Medical Affairs, Inc. | |
Christopher Patrick Smith | Phase 3 |
Bayer | Phase 3 |
Pharmacology for OXYTROL FOR WOMEN
Drug Class | Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Muscarinic Antagonists |
US Patents and Regulatory Information for OXYTROL FOR WOMEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXYTROL FOR WOMEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | OXYTROL FOR WOMEN | oxybutynin | FILM, EXTENDED RELEASE;TRANSDERMAL | 202211-001 | Jan 25, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for OXYTROL FOR WOMEN
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Teva B.V. | Kentera (previously Oxybutynin Nicobrand) | oxybutynin | EMEA/H/C/000532 Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder. |
Authorised | no | no | no | 2004-06-15 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for OXYTROL FOR WOMEN
See the table below for patents covering OXYTROL FOR WOMEN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 6077294 | ⤷ Sign Up | |
New Zealand | 586108 | Compositions and methods for transdermal oxybutynin therapy | ⤷ Sign Up |
Japan | 2017031191 | 経皮オキシブチニン療法のための組成物および方法 (COMPOSITION AND METHOD FOR TRANSDERMAL OXYBUTYNIN THERAPY) | ⤷ Sign Up |
Canada | 2406064 | REDUCTION D'EPISODES INDESIRABLES ASSOCIES A UNE THERAPIE PAR L'OXYBUTYNINE (MINIMIZING ADVERSE EXPERIENCE ASSOCIATED WITH OXYBUTYNIN THERAPY) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OXYTROL FOR WOMEN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0871420 | 05C0008 | France | ⤷ Sign Up | PRODUCT NAME: OXYBUTININ; REGISTRATION NO/DATE: EU/1/03/270/001 20040615 |
0871420 | CA 2005 00010 | Denmark | ⤷ Sign Up | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |